-
16482-10An antimicrotubule agent that binds to &beta-tubulin with a similar order of magnitude as the binding of paclitaxel to &beta-tubulin (IC<sub>50</sub>s = 2.3 and 3.
-
16482-5An antimicrotubule agent that binds to &beta-tubulin with a similar order of magnitude as the binding of paclitaxel to &beta-tubulin (IC<sub>50</sub>s = 2.3 and 3.
-
10924-1A macrolide that causes the formation of bundles of intracellular microtubules in non-mitotic cells, induces the formation of hyperstable tubulin polymers, and arrests cell cycling in mitosis induces mitotic arrest at nanomolar IC50 values in cell
-
10924-10A macrolide that causes the formation of bundles of intracellular microtubules in non-mitotic cells, induces the formation of hyperstable tubulin polymers, and arrests cell cycling in mitosis induces mitotic arrest at nanomolar IC50 values in cell
-
10924-5A macrolide that causes the formation of bundles of intracellular microtubules in non-mitotic cells, induces the formation of hyperstable tubulin polymers, and arrests cell cycling in mitosis induces mitotic arrest at nanomolar IC50 values in cell
-
18765-1A microtubule-stabilizing agent that inhibits the growth of a variety of cancer cells both in vitro (IC<sub>50</sub> values range from 0.97 to 21 nM) and in mice brain penetrant and reduces neurodegeneration in aged tau transgenic mice attenuates
-
18765-10A microtubule-stabilizing agent that inhibits the growth of a variety of cancer cells both in vitro (IC<sub>50</sub> values range from 0.97 to 21 nM) and in mice brain penetrant and reduces neurodegeneration in aged tau transgenic mice attenuates
-
18765-25A microtubule-stabilizing agent that inhibits the growth of a variety of cancer cells both in vitro (IC<sub>50</sub> values range from 0.97 to 21 nM) and in mice brain penetrant and reduces neurodegeneration in aged tau transgenic mice attenuates
-
18765-5A microtubule-stabilizing agent that inhibits the growth of a variety of cancer cells both in vitro (IC<sub>50</sub> values range from 0.97 to 21 nM) and in mice brain penetrant and reduces neurodegeneration in aged tau transgenic mice attenuates
-
C0271-1 mg
Thomas Scientific
Epoxomicin analog and proteasome inhibitor used to treat multiple myeloma. It prevents protein degradation, inducing cell cycle arrest and apoptosis. (C08-0488-717)
Price: $193.86List Price: $215.40Carfilzomib is an analog of epoxomicin that functions as a proteasome inhibitor. This drug has been approved for use in humans with multiple myeloma. -
C0271-5 mg
Thomas Scientific
Epoxomicin analog and proteasome inhibitor used to treat multiple myeloma. It prevents protein degradation, inducing cell cycle arrest and apoptosis. (C08-0489-072)
Price: $320.08List Price: $355.64Carfilzomib is an analog of epoxomicin that functions as a proteasome inhibitor. This drug has been approved for use in humans with multiple myeloma. -
C0271-25 mg
Thomas Scientific
Epoxomicin analog and proteasome inhibitor used to treat multiple myeloma. It prevents protein degradation, inducing cell cycle arrest and apoptosis. (C08-0489-651)
Price: $874.13List Price: $971.26Carfilzomib is an analog of epoxomicin that functions as a proteasome inhibitor. This drug has been approved for use in humans with multiple myeloma.